Skip to main content
Premium Trial:

Request an Annual Quote

Jeffrey Bluestone, Vijay Kuchroo, Christoph Lengauer, Aviv Regev, Ramnik Xavier, Alexis Borisy, Jeff Ross, Anthony Philippakis, Maya Said, Jason Coloma, Susan O'Connor

Celsius Therapeutics has named its founders and leadership team.

The company's founders are Jeffrey Bluestone, president and CEO of the Parker Institute for Cancer Immunotherapy at the University of California, San Francisco; Vijay Kuchroo, professor of neurology at Harvard Medical School; Christoph Lengauer, venture partner at Third Rock Ventures; Aviv Regev, chair of the faculty, core member, and director of the Klarman Cell Observatory at the Broad Institute; and Ramnik Xavier, chief of gastroenterology at Massachusetts General Hospital. Lengauer is also Celsius' president.

Alexis Borisy, a partner at Third Rock Ventures, serves as executive chairman of the company's board of directors, and Lengauer is a board member. Regev is a board observer, along with Jeff Ross, cofounder of Syfr, and Anthony Philippakis, a venture partner at GV (formerly Google Ventures).

The firm's management team includes Maya Said, chief operating officer; Jason Coloma, chief business officer; and Susan O'Connor, chief people officer.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.